Skip to main content
All lobbying filings

SOLUGEN INC

Lobbying for SOLUGEN INC · Industrial Biomanufacturing

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$120,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
Texas

Official filing document

 Government bodies contacted 4
  • Defense, Dept of (DOD)
  • Executive Office of the President (EOP)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Lobbying activity 2
Defense

Support the use of bio-based chemicals in the Department of Defense, generally. FY 2026 Defense Appropriations. FY 2026 National Defense Authorization Act.

Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally. Educate policymakers on the Premanufacture Notice decision for glucaric acid under (P.L. 114-182) the Frank R. Lautenberg Chemical Safety for the 21st Century Act and on the Environmental Protection Agency's chemical review process.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem